The company said it has recorded gusty winds with a speed of 80 km per hour in most of those counties.
The company is also building its APAC research and development center in Yanzhou to deploy the latest innovations and technologies.
The company said Champion, Calvin Klein and Under Armour were the top three foreign brands favored by Chinese consumers. Moreover, the sales of household products, personal care and cosmetics saw robust growth.
The company owns diversified business interests, focusing on aviation, tourism, logistics and financial services with operations worldwide.
The competition's offline preliminary round in the domestic market started in Hong Kong on April 15 and extended to Israel, Germany and the United States. The online competition kicked off in August and attracted around 400 teams from across the world.
The company's new Shanghai Gigafactory, on which work only started in January last year, delivered its first 15 Model 3 sedans on Dec 30, a move marking a major milestone in the manufacturer's global expansion efforts.
网站seo哪家好
The competition, held in Chongqing municipality, allows students aged between 6 and 18 years old to craft sci-fi stories or write creative computer programs in the next eight months to "cultivate students’ interests in science fiction,” according to the organizer.
The company said shipments of chipsets in the first quarter increased over 70 percent from the same period a year ago. To strengthen its position in 5G research, it is on track to start 5G-commercial deployments in the third quarter of 2018.
The company said in a news release it has launched dedicated flights from cities including Hangzhou, Hong Kong and Harbin to multiple international destinations, such as Moscow, Tel Aviv and Liege, Belgium.
The company said a total of 1,120 volunteers were vaccinated during the phase-1 and phase-2 clinical trials, all of whom produced high-titer antibodies. In the 18-to-59-year-old age group, those who got two doses of vaccine based on the 0-and-28-day procedure demonstrated 100 percent antibody positive conversion rate, while those who got two doses based on the 0-and-14-day procedure and 0-and-21-day procedure showed a 97.6 percent antibody positive conversion rate.